Last Updated On 11/25/2019 4:49:37 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Novartis |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: MedImmune |
| Recipient: You |
| Company: Imedex |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Epizyme |
| Recipient: You |
| Company: AstraZeneca/MedImmune |
| Recipient: You |
| Company: ARIAD |
| Recipient: You |
| Company: EMD Serono |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: HERON |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: MedImmune |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: Millennium |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Polaris |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: EMD Serono |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: UptoDate |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|